Active Ingredient: ROFLUMILAST
Proprietary Name: ROFLUMILAST
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 250MCG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A208247
Product Number: 002
Approval Date: Jun 20, 2023
Applicant Holder Full Name: STRIDES PHARMA GLOBAL PTE LTD
Marketing Status:
Prescription
Patent and Exclusivity Information